Search Results 841-850 of 21570 for Inhibition

1. EDIT&RES Trial - Mayo Clinic

   Current use of monoamine oxidase inhibitors or use within 14 days following discontinuation of a monoamine oxidase inhibitors. Presence of mixed symptoms of ...

2. Antidepressants: Another tool against chronic pain

   Selective serotonin reuptake inhibitors (SSRIs). SSRIs may help relieve some types of pain. But there's little proof. SSRIs include paroxetine (Paxil) and ...

3. Pacritinib (oral route) - Side effects & dosage - Mayo Clinic

   If you are using other kinase inhibitors, your doctor may adjust your dose or stop taking other kinase inhibitor medicines before you start treatment with ...

4. Science Saturday: Reversing aging in mice - a new drug target - Mayo Clinic News Network

   Called 78c, it inhibits CD38, a specific enzyme involved on the NAD degradation pathway, leading to the inhibition of a number of pathways that limit the ...

5. Publications - Uma Thanarajasingam, M.D., Ph.D. - Mayo Clinic

   ... Inhibitor Cancer Immunotherapy. J Neuroimmunol. 2025 Jan 15; 398 ... Immune Checkpoint Inhibition-Does It Cause Rheumatic Diseases? Mechanisms of ...

6. Anti-fibrotic therapy in the treatment of IPF: Ongoing concerns and current practices - Mayo Clinic

   Pirfenidone, a well-known anti-fibrotic drug already approved outside the U.S., and nintedanib, a tyrosine kinase inhibitor, both became available ...

7. A Study to Evaluate N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC) - Mayo Clinic

   combined (estrogen or progestogen containing) hormonal contraception associated with the inhibition of ovulation (either oral, intravaginal, or transdermal); ...

8. Breast cancer survivors find relief for debilitating menopause symptom - Mayo Clinic News Network

   However, these antiestrogen therapies, called aromatase inhibitors, also can exacerbate GSM symptoms. Headshot photo of Dr. Anita Chen Anita Chen, M.D.. "Our ...

9. Mayo Clinic experts highlight advances in breast cancer research: Decreasing the need for chemotherapy and reducing the intensity of radiation therapy

   Premenopausal patients with ER+ breast cancer are treated with ovarian function suppression and aromatase inhibitors to lower estrogen levels and slow cancer ...

10. A Study to Evaluate ADP-A2M4 with Pembrolizumab to Treat Recurrent or Metastatic Head and Neck Cancer - Mayo Clinic

    Checkpoint inhibitor naïve and may have received prior platinum containing chemotherapy regimen. Measurable disease according to RECIST v1.1. HLA-A*02 ...